Piramal Alternatives, the fund management arm of Piramal Group, has invested INR 160 crore in Chennai-based pharmaceutical company Saimirra Innopharm through its India Credit Opportunities Fund II ...

Piramal Alternatives, the fund management unit of Piramal Group, said Tuesday it has invested about Rs 160 crore ($18.8 million) in Chennai-based Saimirra Innopharm Pvt Ltd through its performing ...

Sai Mirra Innopharm, a pharma player in the domestic and rest of the world (ROW) formulations market, has raised ₹160 crore from Piramal Alternatives, the fund management division of the Piramal ...